Literature DB >> 35352025

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute.

Kelvin César de Andrade1, Elaine E Lee2, Elise M Tookmanian3, Chimene A Kesserwan4, James J Manfredi5, Jessica N Hatton1, Jennifer K Loukissas3, Jiri Zavadil6, Lei Zhou7, Magali Olivier6, Megan N Frone1, Owais Shahzada8, William J R Longabaugh2, Christian P Kratz9, David Malkin10, Pierre Hainaut11, Sharon A Savage12.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35352025      PMCID: PMC9090805          DOI: 10.1038/s41418-022-00976-3

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


× No keyword cloud information.
  19 in total

Review 1.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

Review 2.  Inherited TP53 Mutations and the Li-Fraumeni Syndrome.

Authors:  Tanya Guha; David Malkin
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 3.  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.

Authors:  Gerd P Pfeifer; Mikhail F Denissenko; Magali Olivier; Natalia Tretyakova; Stephen S Hecht; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

4.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

Authors:  Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V Tavtigian; Pierre Hainaut; Magali Olivier
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

Review 5.  Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.

Authors:  Amina Amadou; Maria I W Achatz; Pierre Hainaut
Journal:  Curr Opin Oncol       Date:  2018-01       Impact factor: 3.645

6.  Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Authors:  Shunsuke Kato; Shuang-Yin Han; Wen Liu; Kazunori Otsuka; Hiroyuki Shibata; Ryunosuke Kanamaru; Chikashi Ishioka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 11.205

7.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Authors:  Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

8.  Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.

Authors:  Christian P Kratz; Claire Freycon; Kara N Maxwell; Kim E Nichols; Joshua D Schiffman; D Gareth Evans; Maria I Achatz; Sharon A Savage; Jeffrey N Weitzel; Judy E Garber; Pierre Hainaut; David Malkin
Journal:  JAMA Oncol       Date:  2021-12-01       Impact factor: 31.777

9.  The FAIR Guiding Principles for scientific data management and stewardship.

Authors:  Mark D Wilkinson; Michel Dumontier; I Jsbrand Jan Aalbersberg; Gabrielle Appleton; Myles Axton; Arie Baak; Niklas Blomberg; Jan-Willem Boiten; Luiz Bonino da Silva Santos; Philip E Bourne; Jildau Bouwman; Anthony J Brookes; Tim Clark; Mercè Crosas; Ingrid Dillo; Olivier Dumon; Scott Edmunds; Chris T Evelo; Richard Finkers; Alejandra Gonzalez-Beltran; Alasdair J G Gray; Paul Groth; Carole Goble; Jeffrey S Grethe; Jaap Heringa; Peter A C 't Hoen; Rob Hooft; Tobias Kuhn; Ruben Kok; Joost Kok; Scott J Lusher; Maryann E Martone; Albert Mons; Abel L Packer; Bengt Persson; Philippe Rocca-Serra; Marco Roos; Rene van Schaik; Susanna-Assunta Sansone; Erik Schultes; Thierry Sengstag; Ted Slater; George Strawn; Morris A Swertz; Mark Thompson; Johan van der Lei; Erik van Mulligen; Jan Velterop; Andra Waagmeester; Peter Wittenburg; Katherine Wolstencroft; Jun Zhao; Barend Mons
Journal:  Sci Data       Date:  2016-03-15       Impact factor: 6.444

10.  Mutational processes shape the landscape of TP53 mutations in human cancer.

Authors:  Andrew O Giacomelli; Xiaoping Yang; Robert E Lintner; James M McFarland; Marc Duby; Jaegil Kim; Thomas P Howard; David Y Takeda; Seav Huong Ly; Eejung Kim; Hugh S Gannon; Brian Hurhula; Ted Sharpe; Amy Goodale; Briana Fritchman; Scott Steelman; Francisca Vazquez; Aviad Tsherniak; Andrew J Aguirre; John G Doench; Federica Piccioni; Charles W M Roberts; Matthew Meyerson; Gad Getz; Cory M Johannessen; David E Root; William C Hahn
Journal:  Nat Genet       Date:  2018-09-17       Impact factor: 38.330

View more
  3 in total

1.  Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance.

Authors:  Kristina B Emdal; Nicolàs Palacio-Escat; Caroline Wigerup; Akihiro Eguchi; Helén Nilsson; Dorte B Bekker-Jensen; Lars Rönnstrand; Julhash U Kazi; Alexandre Puissant; Raphaël Itzykson; Julio Saez-Rodriguez; Kristina Masson; Peter Blume-Jensen; Jesper V Olsen
Journal:  Cell Rep       Date:  2022-08-09       Impact factor: 9.995

Review 2.  P63 and P73 Activation in Cancers with p53 Mutation.

Authors:  Bi-He Cai; Yun-Chien Hsu; Fang-Yu Yeh; Yu-Rou Lin; Rui-Yu Lu; Si-Jie Yu; Jei-Fu Shaw; Ming-Han Wu; Yi-Zhen Tsai; Ying-Chen Lin; Zhi-Yu Bai; Yu-Chen Shih; Yi-Chiang Hsu; Ruo-Yu Liao; Wei-Hsin Kuo; Chao-Tien Hsu; Ching-Feng Lien; Chia-Chi Chen
Journal:  Biomedicines       Date:  2022-06-23

3.  Pepper Alkaloid Piperine Increases Radiation Sensitivity of Cancer Cells from Glioblastoma and Hypopharynx In Vitro.

Authors:  Sascha Diehl; Guido Hildebrandt; Katrin Manda
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.